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Abstract Crystals of transmembrane proteins may be grown
from detergent solutions or in a matrix of membranous lipid
bilayers existing in a liquid crystalline state and forming a cubic
phase (in cubo). While crystallization in micellar solutions
appears analogous to that for soluble proteins, crystallization
in lipidic matrices is poorly understood. As this method was
shown to be applicable to several membrane proteins, under-
standing its mechanism will facilitate a rational design of
crystallization, minimizing the laborious screening of a large
number of parameters. Using polarization microscopy and low-
angle X-ray diffraction, experimental evidence is provided to
support a mechanistic model for the in cubo crystallization of
bacteriorhodopsin in a lipid matrix. Membrane proteins are
thought to reside in curved lipid bilayers, to diffuse into patches
of lower curvature and to incorporate into lattices which
associate to form highly ordered three-dimensional crystals.
Critical testing of this model is necessary to generalize it to other
membrane proteins. ß 2001 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
Genomic sequencing has revealed that approximately one
third of all genes encode membrane proteins having at least
one membrane-spanning helix [1]. A complete understanding
of the function of integral membrane proteins requires knowl-
edge of their three-dimensional structure at or near atomic
resolution. The major bottleneck en route to obtaining high-
resolution structures of membrane proteins is the preparation
of di¡raction quality single crystals. A paradigm of a mem-
brane protein is the light-driven proton pump, bacteriorho-
dopsin (bR), with its seven transmembrane helices. bR has
long been a target for conventional crystallization using mixed
detergent^protein micelles. With one exception [2], this meth-
odology has yielded bR crystals of comparably low di¡raction
quality, in which the protein is in a functional state markedly
di¡erent from the native one. In contrast, the recently intro-
duced concept of membrane protein crystallization in lipidic
cubic phases [3] has produced crystals of functional bR [4] of
exceptional di¡raction quality. These have been instrumental
in resolving the high-resolution structure of bR in the ground
state at increasing resolution [5^8]. These structures reveal the
intricate interactions between bR, native purple membrane
lipids, and water molecules, in an environment closely resem-
bling that of the cell membrane. Recently, lipidic cubic phase-
grown bR crystals were instrumental in yielding high-resolu-
tion structures of photocycle intermediates [9^14], which
should eventually allow a complete understanding of the pro-
ton pumping mechanism of the molecule at the atomic level.
Moreover, we have recently demonstrated that bR crystals
can also be grown in a lipidic cubic phase directly from the
native membrane without exposure to any detergent [15]. Fi-
nally, we and others have extended the method and demon-
strated that the lipidic matrix used for in cubo (forming a
cubic phase) crystallization allows the formation of three-di-
mensional crystals with membrane proteins di¡ering with re-
spect to the size of their membranous and extramembranous
domains [16,17].
Theoretical aspects of lipidic mesophases have been studied
in detail [18], but our knowledge of the interactions of mem-
brane proteins with such phases remains limited. Recently,
triggered by the success of crystallizing membrane proteins
from lipidic cubic phases, a number of reports that discuss
issues related to the interaction of membrane proteins with
lipidic cubic phases have appeared [19^23].
Using the crystallogenesis of bR, we present experimental
evidence in support of a hypothesis for the molecular mecha-
nism of in cubo crystallization, which was originally proposed
by Landau and Rosenbusch [3], and later developed further
[19^23]. The hypothesis describes how the protein, upon re-
constitution into the continuous curved membrane of the cu-
bic phase, traverses its convoluted and highly curved bilayer
and eventually forms a lamellar-type packing arrangement
within a crystal.
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2. Material and methods
2.1. bR crystal growth in X-ray capillaries and glass vials
Data reported in Figs. 1, 2, 3 and 5 are from crystallization experi-
ments in glass vials, conducted as described [3]. Data reported in
Table 1 and Fig. 4 are from crystallization experiments in capillaries.
Monoolein (MO) (monooleoyl-rac-glycerol [C18:1c9]) from NuCheck
(MN, USA) was mixed with a bR solution (concentrations as in [23])
to form a transparent, highly viscous cubic phase [3,23] using a sy-
ringe-based mixer [24], injected into 1 mm quartz capillaries (Supper
Inc.) and sealed. This pre-crystallization mix consisted of ca. 60%
(w/w) MO and 40% (w/w) bR solution. The ¢nal MO concentration
of similarly prepared binary MO/water mixtures, determined gravi-
metrically, was 61.4 þ 1.7% (w/w). bR crystallization in quartz capil-
laries was initiated by adding 0.3 g ¢nely ground SÖrensen salt (94.8 g
KH2PO4 and 5.2 g NaH2PO4WH2O) per 1 g of pre-formed cubic
phase, or by adding an approximately equal amount of lipidic cubic
phase consisting of 60% (w/w) MO and 40% (w/w) water mixed with
0.552 mg SÖrensen salt/mg of the pre-crystallization mix.
Crystallization of bR was also induced by partial sample dehydra-
tion. For this purpose the pre-crystallization matrix mix, prepared in a
glass vial, was incubated with an excess of 0.4 M SÖrensen salt solu-
tion (pH 5.6) for 2 months. Under these conditions, no bR crystals
were observed. The surplus solution was then removed and the lipid
matrix was allowed to dry for several minutes, reducing its weight by
ca. 4%. Some of the lipid matrix was then ¢lled into capillaries. Crys-
tals grown in glass vials and capillaries were observed by light micros-
copy.
2.2. Enzymatic digestion and crystal dissolution
Enzymatic digestion of the MO in the lipidic cubic phase was con-
ducted as described [25]. Dissolution was induced by overlaying a
crystallization setup containing fully grown crystals with an equal
volume of water.
2.3. Low-angle X-ray di¡raction
X-rays (1.5418 Aî ) were generated by a rotating anode (18 kW, RU-
300; Rigaku). Sample-to-detector distance (ca. 250 mm) was deter-
mined using silver behenate as a standard [26]. Samples were exposed
for 30^60 min and di¡raction images were collected behind a ca. 1 inch
wide slit on a 200U250 mm image plate (Fuji HR-IIIN) and read with
a phosphor image scanner (Storm 840) at a resolution of 100 Wm/pixel
[27]. Powder patterns were integrated radially using FIT2D. Sub-
sequent Gaussian ¢tting was done using ORIGIN 5.0. The limit of
detection of a coexisting second mesophase was estimated to be ca.
5%. All measurements were performed at 21‡C in dim red light.
2.4. Calculation of curvature
Based on the assumptions outlined in [28], the average Gaussian
curvature Kave was calculated as
Kave  2ZM=Aoa2 1
where M is the Euler^Poincare¤ characteristic and Ao is the ratio of the
minimal surface in a unit cell to the quantity (unit cell volume, a)2=3.
For a thorough theoretical discussion, see [29]. Values were
Ao = 3.091, M=38 and Ao = 1.919, M=32 for the cubic-Ia3d and cu-
bic-Pn3m phases, respectively. Lipid length in the cubic-Pn3m phase
at 21‡C was 17.3 Aî [28].
3. Results
3.1. Phenomenology of in cubo crystallization of bR
Prior to crystallization, bR is added to the cubic phase
either from a detergent solution [3,23] or in the form of purple
membrane [15]. In a typical in cubo crystallization mixture,
V10 purple membrane lipids, V750 N-octyl-L-glucoside, and
V15 000 MO molecules were present per detergent-solubilized
bR monomer. The detergent concentration was calculated
from the initial concentration in the bR solution, and from
the decrease in volume during the concentration step, as de-
scribed in [3]. The protein is uniformly dispersed throughout
the lipid matrix, as evidenced by the homogeneous purple
color of the material (Fig. 1A). The protein remains in this
state for time periods exceeding years (data not shown). Crys-
tallization is initiated by the addition of solid SÖrensen salt.
Three-dimensional purple crystals of bR grow within the bulk
cubic phase, while the matrix purple color fades visibly. This
phase transformation is facilitated by di¡usion of bR mole-
cules from the host bulk cubic phase and their incorporation
into the growing crystals. The ¢rst bR crystals appear in the
vicinity of the salt crystals, and as crystallization progresses,
crystals form throughout the bulk cubic phase (Fig. 1B). The
number of crystals decreases and their size increases as a
function of distance from the salt. Crystal growth in cubo is
accompanied by the appearance of a small volume of colorless
aqueous solution that contains salt crystals in contact with the
lipidic cubic phase. Altogether, four distinct macroscopic
phases can be observed in the mature samples: (i) colorless
lipidic cubic phase, (ii) purple bR crystals, (iii) salt crystals,
and (iv) colorless aqueous solution surrounding the salt crys-
tals. Hence, the initially homogeneous two-phase system com-
posed of lipidic cubic phase and salt evolves into a four-phase
system.
Upon microscopic inspection with cross-polarized light, bR
crystals appear to have a pink hue and are enveloped by a
layer of blue birefringence several micrometers thick, whereas
the bulk cubic phase appears non-birefringent (Figs. 2 and 3).
The blue birefringence is indicative of a non-isotropic lipidic
phase, possibly a lamellar phase [20,21]. It disappears upon
enzymatic removal of the host lipid (Fig. 2, inset) [25]. Hence,
a physical connection between the protein layers in the crystal
and the curved bilayer of the lipidic cubic phase, via a lipid
bilayer such as a portal lamellar phase, may exist [20,21].
3.2. Low-angle X-ray di¡raction
Bulk phase states of the lipidic matrices containing bR were
determined by low-angle X-ray di¡raction at di¡erent stages
Fig. 1. Microscopic images of the crystallization of bR in the lipidic
matrix, conducted as described [3]. The upper and middle parts of
each image show the lipidic matrix and bR, lower parts depict solid
SÖrensen salt. A: Crystallization setup 2 days after addition of the
salt. Most of the purple color (bR) is still distributed homogene-
ously in the lipidic matrix, and some purple microcrystals have
started to form close to the SÖrensen salt. B: A second crystalliza-
tion set up after 2 months. bR crystals with sizes up to 40 Wm have
formed. The crystals are surrounded by a colorless lipidic cubic
phase.
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in the crystallization experiments. Table 1 summarizes the
results. Initially, bicontinuous lipidic cubic phases of space
groups Pn3m and Ia3d, as well as a lamellar phase, were
identi¢ed. These phases also occur in binary mixtures of
MO and water, for which detailed lyotropic and thermotropic
phase diagrams have been established [28,30]. The number,
identity of di¡erent phases, and their unit cell size at the initial
stage of the process depends on the L-octyl glucopyranoside
(OG) and SÖrensen salt concentrations. High levels of OG
favor LK phase formation. In like manner, the OG homolog,
dodecyl maltoside, has been shown to destabilize the cubic
mesophase in hydrated MO [31]. Addition of SÖrensen salt
resulted either in a signi¢cant decrease of the cubic phase
lattice parameter or in phase transitions prior to appearance
of bR crystals. Both phenomena are accompanied by an in-
crease in bilayer curvature. An increase of the initial salt con-
centration resulted in the pre-crystallization lipid phase being
of the cubic-Pn3m type, thereby enabling the entire crystalli-
zation process to occur without a lipid phase transition. bR
crystals did not form when the crystallization experiment was
initiated from a lamellar liquid crystal phase or when the ¢nal
phase was of the cubic-Ia3d type.
Crystallization experiments were accomplished by adding
various amounts of SÖrensen salt to the bR-containing MO
Fig. 2. bR crystals grown in the MO lipidic matrix in glass vials [3]
are surrounded by a non-cubic, birefringent lipidic phase. Crystals
grown in a MO lipid matrix were viewed using a light microscope
without (A) and with (B) crossed polarizers. A: Purple bR crystals
are embedded in a colorless, transparent lipid phase. B: Light blue
birefringence around bR crystals. A single crystal in water that was
removed from the lipidic phase by enzymatic digestion of MO lacks
the surrounding blue birefringence (insets on top right section of
images A and B). Crystal sizes are ca. 30^40 Wm.
Fig. 3. Analysis of the birefringence surrounding a single bR crystal
grown in the lipidic matrix in glass vials [3]. Crystal is viewed edge
on, i.e., the large hexagonal ab face is perpendicular to the plane of
the ¢gure. A: bR crystal surrounded by birefringent glow. The hori-
zontal section used for the quantitative analysis of brightness is
marked by a rectangle. The crystal itself exhibits a pink birefrin-
gence. The crystal surfaces are darker than the bulk. B: Brightness
of section through the crystal. The crystal is ca. 15 Wm thick. Two
regions that vary in brightness encompass the crystal and protrude
ca. 3^5 Wm into the lipidic cubic phase on each side. Partial bire-
fringence in lipid phases is commonly caused by crystalline or non-
cubic domains.
Fig. 4. E¡ect of SÖrensen salt on the phase behavior of MO and on
the bR crystal size. These experiments were conducted in capillaries.
A: Type and lattice parameter of the lipidic cubic phases, deter-
mined by low-angle X-ray di¡raction, as a function of SÖrensen salt
concentration. Filled circles, cubic-Pn3m; open squares, cubic-Ia3d.
Kave was calculated using Eq. 1. B: Average bR crystal size as a
function of SÖrensen salt concentration. Sizes were determined by
measuring the longest axis of at least 10 fully grown (s 3 months)
hexagonal crystals. Error bars show standard deviations. Below an
equivalent amount of 0.1 mg salt added to 1 mg pre-crystallization
mix, no crystals were observed after 1 year. Note that the Ia3d-to-
Pn3m lipid phase transition observed (in A) does not coincide with
the onset of bR crystallization (in B).
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cubic phase (Fig. 4). Below a critical threshold amount of
SÖrensen salt, no bR crystals formed. The minimum amount
of SÖrensen salt necessary for crystallization to occur was
approximately 0.1 mg salt for 1 mg of pre-crystallization
mix. Under these conditions, crystals attained their largest
size, and the lattice parameter of the host cubic-Pn3m phase
was ca. 93.5 Aî , corresponding to an average Gaussian curva-
ture of 37.5W1034 Aî 32. Dehydration of the lipidic material,
starting at either low (100 mM) or high (400 mM) salt con-
centrations, also yielded micro crystals (Fig. 5), giving rise to
a new crystallization procedure, and demonstrating that the
ionic strength per se is not solely responsible for bR crystal
formation. During dehydration, the loss of water was deter-
mined to be only 4% of the total weight. Therefore, the salt
concentration increase in the aqueous compartment of the
cubic phase is V8%. Since such crystallization-by-dehydra-
tion-experiments can be carried out with a starting concentra-
tion varying from 100 to 400 mM, the major crystallization-
inducing e¡ect is possibly caused by alterations of the lipidic
compartment of the cubic phase, rather than by an increase in
the ion concentration of the aqueous compartment.
4. Discussion
4.1. Crystallization phenomenology in the context of
lipidic phase behavior
Our approach to deciphering the mechanism of crystalliza-
tion of membrane proteins in cubo [3,14^16,19^23] is based
on investigating the lyotropic phase behavior of the MO/water
system [21,28,30]. Formation of two-dimensional crystalline
arrays of bR was shown to require SÖrensen salt and was
driven by speci¢c interactions between bR and the major
anionic purple membrane lipids: 2,3-di-O-phytanyl-sn-glyc-
ero-1-phosphoryl-3P-sn-glycerol 1P-phosphate and 2,3-di-O-
phytanyl-sn-glycero-1-phosphoryl-3P-sn-glycerol 1P-sulfate
[32^34]. Despite the di¡erent conditions prevailing in three-
dimensional in cubo crystallization, some mechanistic aspects
contributing to phase separation into two-dimensional lipid^
protein arrays, as predicted by a simple stochastic model [35],
and independently by a molecular ¢eld theory [36], might
apply in cubo. Because all processes required to e¡ect in
cubo crystallization as described here are performed at
21‡C, the respective isotherm in the temperature^composition
phase diagram of the MO/water system can be used as a
guideline [21,23,28,30]. At this temperature, the hydrated cu-
bic phase is at or close to full hydration. Upon dehydration,
Table 1
Lipid phases and their lattice parameters, as determined in crystallization experiments
Initial composition of crystallization
matrixa
Result Mesophase identity and microstructure characteristics















20 mM SÖrensen salt, ca. 0.15 M OG. no bR crystals
observed
LK 50 0 Ia3d 140 38.3
(addition of solid SÖrensen saltb)
20 mM SÖrensen salt, ca. 0.12 M OG. bR crystallization LK 47 0 Pn3m 87 38.7
(addition of solid SÖrensen saltb) Ia3d 140 38.3
20 mM SÖrensen phosphate,
ca. 75 mM OG
bR crystallization Ia3d 145 37.7 Pn3m 87 38.7
(addition of solid SÖrensen saltb)
300 mM SÖrensen salt,
ca. 75 mM OG
bR crystallization Pn3m 104 36.1 Pn3m 92 37.7
(addition of solid SÖrensen saltb)
Pre-incubation of crystallization matrixa
with 0.4 M SÖrensen salt solution,
ca. 75 mM OG
bR crystallization
(Fig. 5)
Pn3m 102 36.3 Pn3m 87 38.7
(removal of excess solution, partial
dehydration)
Mature crystallization setup with 3 M
SÖrensen salt, ca. 75 mM OG
bR crystal
dissolution
Pn3m 86 38.9 Pn3m 98 36.8
(addition of an equal volume of water
to a mature crystallization setup
containing bR crystals)
Phase identi¢cation and microstructure determination were made by low-angle X-ray di¡raction. Measurements were performed on samples in
quartz capillaries in dim light at 21‡C. Representative lattice parameter values are reported.
aPre-crystallization setups contained 60% (w/w) MO, 40% (w/w) protein solution, 3.5 mg bR/ml.
bCrystallization was induced by adding the SÖrensen salt mixed with MO and water, as described in Section 2.1.
Fig. 5. Collection of bR microcrystals grown by dehydration of the
lipidic cubic phase material, in the absence of added SÖrensen salt
(see Table 1). Hexagonal, cubic and rhomboid crystal morphologies
are present along with amorphous shaped objects. Microscopic im-
ages were taken with phase contrast optics. Bar represents 5 Wm.
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the bilayer curvature of the cubic phase increases, triggering a
cubic-to-lamellar phase transformation at su⁄ciently low hy-
dration. The membrane protein crystallization experiment can
be understood in this context [19^23]: added precipitant com-
petes with the lipid for available water, thereby lowering the
activity of water. Thus, the salt e¡ectively destabilizes the
cubic phase in favor of a lamellar phase. Crystallization
does not require a complete cubic-to-lamellar phase transfor-
mation. Rather, the crystallization mechanism calls for a
small amount of lamellar phase that may be encountered at
the point of phase coexistence. The cubic phase may thus be
contiguous with a lamellar phase, acting as an orienting portal
for the protein between the feeder cubic phase and the crystal,
which acts as a sink.
4.2. Membrane curvature and mismatch
Because the number of MO and water molecules in the in
cubo crystallization system far outnumber that of bR mole-
cules, formation of a macroscopically undisturbed cubic phase
is possible. On the microscopic level, there are, however, con-
sequences due to the presence of one bR molecule in one out
of ¢ve unit cells of the Ia3d phase (unit cell dimension, a = 145
Aî [28]), or in one out of 13 unit cells of the Pn3m (a = 104 Aî )
phase prior to crystallization. The molecular dimensions of
bR and the matrix lipid MO are markedly di¡erent, both in
length (bR, ca. 33 Aî ; MO, 17.3 Aî ) and diameter (bR, 25 Aî ;
MO, V4^5 Aî ) of the respective hydrophobic, roughly cylin-
drically shaped moieties (numbers for bR are from RCSB
database accession code 1QHJ). Therefore, the precise regular
geometric pattern of the bicontinuous cubic phase cannot be
maintained in unit cells harboring bR molecules. In the fol-
lowing, we present a qualitative outline of the interactions of
membrane proteins with negatively curved membranes such as
bicontinuous cubic phases. We conclude that such interactions
are least favorable under conditions of high-curvature com-
pared to those between membrane protein and lipids in lamel-
lar-type crystals, thereby constituting the driving force for
crystallization in cubo.
The precise location of transmembrane proteins within
curved bilayers that constitute the lipidic cubic phase is un-
known. However, based on the increased stability of bR in the
lipidic matrix and the reasoning outlined in Loewen et al. [20],
it is reasonable to assume that the protein is reconstituted into
the curved MO bilayer. The protein may be considered to be
in a taut state, presumably caused by a curvature-related hy-
drophobic mismatch at the lipid^protein boundary (schemati-
cally shown in Fig. 6). This mismatch is conceptually similar
to the one described for wedge-shaped proteins in a bent
bilayer [37], which incurs an energy penalty. In contrast, in
a planar setting of the correct thickness, such mismatch is
minimized (Fig. 6C). Such a penalty is presumably minimized
by a local deviation of the membrane curvature from its reg-
ular pattern (Fig. 6C). We have demonstrated that an increase
in curvature is brought about by the addition of salt to the
MO matrix. The described mismatch can be resolved by ef-
fecting a phase separation of the host lipidic cubic phase into
a highly curved cubic phase lacking membrane defects, and a
lamellar crystalline protein array.
4.3. Crystallization model
The mechanism of nucleation and crystal growth of bR in
lipidic cubic phases [3,19^23] is proposed to take place in four
or ¢ve consecutive steps (Fig. 7). Monomeric bR in the mi-
cellar state [38] may be treated as a rigid body, and thus
possesses six degrees of freedom, three translational and three
rotational. Reconstitution into the bilayer of the lipidic cubic
phase limits the mobility of the protein; speci¢cally, it reduces
the number of degrees of freedom by two rotational and one
translational, resulting in a system with a total of three de-
grees of freedom [39]. The crystallization entropy, which is the
entropic penalty of immobilizing particles during crystalliza-
tion, is therefore partly compensated for by this reconstitution
prior to the crystallization process. In the case of crystalliza-
tion starting with the purple membrane incorporated into the
cubic phase [15], reconstitution of two-dimensional purple
patches or smaller units, possibly bR monomers, into the
three-dimensional membranous network might occur. Cubic
phase-incorporated bR molecules are pre-oriented by the bi-
layer, such that the seven transmembrane K-helices reside
Fig. 6. Hydrophobic matching at the protein^membrane interface in
membranous media with diverse curvatures. Membrane proteins are
shown schematically as cylinders. Lipid bilayers are depicted as pla-
nar or curved structures. To the left they are shown (from the top)
in their respective environments. The middle column shows the bor-
ders of interaction with the hydrophobic environment. The rectan-
gles in the right column represent rolled-out versions of the cylinder
surfaces with their matching hydrophobic surfaces as dark shaded
areas. Mismatch between the two surfaces is shown as lightly
shaded areas. A: Protein cylinder interacting with (1) a planar mem-
brane; (2) with a detergent girdle around its transmembrane sec-
tion; and (3) with neighboring protein molecules. These represent
bR in a planar lipid bilayer, in a detergent micelle and in the purple
membrane crystalline array, respectively. In all three cases, the hy-
drophobic surface of the transmembrane region of the protein is en-
tirely matched with a complementary hydrophobic surface of lipid,
detergent or protein. B: Membrane protein interacting with a nega-
tively curved bilayer such as that of a bicontinuous cubic phase.
The transmembrane region of the protein matches partially with the
hydrophobic sections of the bilayer. This mismatch is energetically
unfavorable and the degree of mismatch may be reduced by a local
distortion of the membrane. C: Restored matching of hydrophobic
surfaces of the membrane with that of the protein. In order to
achieve this, a local membrane distortion is required, causing bend-
ing frustration.
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within the hydrophobic core of the membrane, and the loop
regions are solubilized in the aqueous channels. Moreover, the
lateral di¡usion pathways are de¢ned by the structure of the
curved lipid bilayer. This greatly increases the ratio of pro-
ductive to non-productive protein encounters that are neces-
sary for crystal nucleation and growth.
As outlined in Fig. 6, the presence of planar patches of
membrane protein molecules in the bilayer of the cubic phase
is incompatible with the geometric constraints of the curved
membrane. Accordingly, we postulate the formation of local
curvature defects surrounding the embedded membrane pro-
tein. Similar local curvature distortions in comparable systems
were shown to di¡use and to merge with each other, thereby
decreasing the curvature distortion [40]. Furthermore, curva-
ture-induced particle concentration in a bilayer has been de-
scribed on a theoretical basis for a similar system [41]. Anal-
ogously, we reason that a curvature-induced aggregation of
bR and purple membrane lipids occurs above a certain thresh-
old. Partitioning of bR molecules into an adjacent local pla-
nar domain relieves strain. In cases where the protein is tightly
bound to native lipids, it may be escorted by native lipids
through the entire crystallization process. bR exhibits this
type of lipidic chaperoning [42] and we suggest that the ten-
dency of purple membrane lipids to form planar sheets [43]
contributes to nucleation of this phase separation. Crystal
growth in the lipid^protein plane may be envisaged by lateral
merging of protein and of small purple membrane-like units,
guided by the matrix bilayer. Indeed, a recent statistical ther-
modynamics analysis of membrane bending-mediated pro-
tein^protein interaction revealed that, in the regime of nega-
tive Gaussian curvature, the interactions between proteins are
attractive [44]. The structure of the portal membrane may
resemble that of phase transition intermediates, as observed
in bicontinuous cubic-to-lamellar phase transitions [45], in
membrane fusion [46], or in sponge phases [47]. Interestingly,
coexistence of the cubic-Pn3m phase with lamellar structures
of the LK type has not been identi¢ed in the pure, two-com-
ponent MO/water model system [30]. The high-resolution
structure of bR reveals hexagonal packing of trimers in the
a^b plane, while adjacent planes are related by a two-fold
Fig. 7. A hypothesis of the steps leading to the formation of three-dimensional crystals [20,21,23] by incorporation of bR into curved lipid bi-
layers and subsequent phase separation into lamellar structures. The amphipathic species bR, purple membrane lipids, and detergent partition
into the curved membrane of the cubic phase and may di¡use freely therein. Panel A: Schematic description of events occurring during the
crystallization of bR in lipidic mesophases. Purple patches (1) or detergent-solubilized monomers (2) insert spontaneously into the curved bi-
layer (3) of the bicontinuous cubic-Pn3m phase. Addition of SÖrensen salt increases the membrane curvature and reduces unit cell size
((3)C(4)). Signi¢cant cubic unit cell deformations due to the presence of the protein may occur at this stage. Separation of protein and purple
membrane lipid from the highly curved cubic phase bilayer into growing planar domains favors crystal nucleation. Bending frustration is re-
lieved by this process, which occurs by means of lateral di¡usion analogously to defect migration and fusion described for similar systems [39].
Di¡usion of a misaligned membrane protein along the curved membrane to an adjacent layer may enable a crystallographic match with the
growing crystal. Portal lamellae and a putative intermittent sponge phase connect the protein crystal with the surrounding cubic phase. The
crystallization process is completed when mature crystals coexist with a bR-depleted and highly curved cubic phase (5). Upon reswelling of the
cubic phase by hydration, the crystallization process may be reversed and protein molecules di¡use back into the curved bilayer via the portal
lamellae. Panel B: Schematic representation of the various states of protein^membrane interactions encountered during the crystallization pro-
cess (see also Fig. 6), and the changes in free energy (vG).
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screw axis along the c-direction, forming polar P63 crystals [5].
Crystallographic and mass spectroscopic analyses of the crys-
tals have revealed the presence of at least four di¡erent lipid
species and their precise location within and around the bR
trimer [7,8]. Thus, protein molecules and purple membrane
lipids are arranged in lamellar sheets in the crystal, adopting
the same orientation with respect to the membrane plane as
that assumed by bR in the native membrane. Negative charges
on the hydrophilic surface of the AB and the BC loops and of
purple membrane lipid must be screened by cations in order
to establish the crystal contacts along the c-axis. The weak
contacts along this axis are manifested by the tendency of bR
crystals to form twinned crystals [6]. This type of twinning
may be overcome by appropriate crystallization conditions [7].
This model explains the macroscopic, as well as the micro-
scopic, phenomena associated with bR crystallization in the
lipidic matrix. Consistent with the presence of a lamellar
membranous network connecting crystal and bicontinuous
cubic phase is the observation that dissolution of bR crystals
can be induced by slightly rehydrating the cubic phase
(Table 1).
4.4. Concluding remarks
The proposed mechanism is based on experiments with bR
as outlined above, and its extension to and validity for other
proteins should be tested. For example, replacing the curva-
ture-increasing agent (SÖrensen salt) in crystallization experi-
ments by others, such as polyethylene glycol [48] should lead
to crystal formation. Indeed, bR crystals can be grown in a
cubic matrix by slow dehydration (Fig. 5). Conversely, an
increase in pressure that decreases membrane curvature [49]
should facilitate crystal dissolution. For the proteins that have
so far been crystallized in cubo [3,16,17], we expect to identify
di¡erent curvature thresholds due to their disparate size and
transmembrane shape. Finally, we expect that additional ex-
amples of membrane protein crystals grown in cubo will re-
veal packing arrangements similar to that of bR. According to
the model proposed here, layered packing is uniquely compat-
ible with a physical feeding portal connecting the crystalline
protein moieties with the surrounding bicontinuous lipidic
cubic phase.
The content of and packing arrangement in bR crystals
demonstrates that care needs to be taken during puri¢cation
of membrane proteins in order to prevent total delipidation.
Alternatively, addition of a⁄ne lipids to crystallization sys-
tems may prove bene¢cial. We envisage that these insights
will form a basis for successful crystallization of membrane
proteins in cubo, en route to determining their structures in
association with lipids.
The mechanism described here, and in the literature [3,19^
23], provides a qualitative explanation of the process of crys-
tal nucleation and growth. A thorough quantitative under-
standing of the energetics of interaction of curved membranes
with embedded membrane proteins must be established in
order to describe precisely the intricate details of the crystal-
lization process. Nonetheless, membrane protein crystalliza-
tion trials along the lines of the in cubo strategy may pro¢t
from the insight gained already on this descriptive level.
5. Note added in proof
Recently, the in cubo crystallization approach yielded well-
di¡racting crystals of sensory rhodopsin II, the structure of
which was solved independently by two groups to 2.1 Aî res-
olution [50] and 2.4 Aî resolution [51].
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